AbbVie and Teneobio Announce a Strategic Transaction to Develop a New Treatment for Multiple Myeloma Read more
Neurogene Raises $68.5 Million in Series A Financing to Advance Multiple Programs in Devastating Neurological Diseases Read more
Amyris Is Selected by NIH Grant Recipient, IDRI, to Engineer Molecules for Vaccine Adjuvant Applications Read more
FDA Advisory Committee Recommends Approval of SPRAVATO (esketamine) Nasal Spray CIII for Adults with Treatment-Resistant Depression Read more